Therapeutic microRNAs in human cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology
Link
http://link.springer.com/article/10.1007/s10616-018-0291-8/fulltext.html
Reference180 articles.
1. Abba ML, Patil N, Leupold JH et al (2017) MicroRNAs as novel targets and tools in cancer therapy. Cancer Lett 387:84–94
2. An Z, Ren J, Yang G et al (2015) MicroRNA let-7: regulation, single nucleotide polymorphism, and therapy in lung cancer. J Cancer Res Ther 11:1. https://doi.org/10.4103/0973-1482.163830
3. Avgeris M, Stravodimos K, Fragoulis EG, Scorilas A (2013) The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients. Br J Cancer 108:2573. https://doi.org/10.1038/bjc.2013.250
4. Babar IA, Cheng CJ, Booth CJ et al (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci 109:E1695–E1704. https://doi.org/10.1073/pnas.1201516109
5. Babashah S, Soleimani M (2011) The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47:1127–1137. https://doi.org/10.1016/j.ejca.2011.02.008
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate PTEN in Triple Negative Breast Cancer;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-11
2. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma;Frontiers in Bioscience-Landmark;2024-05-13
3. Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma;International Journal of Molecular Sciences;2024-02-20
4. SIRT1 regulates endoplasmic reticulum stress-related organ damage;Acta Histochemica;2024-01
5. MicroRNAs as a theranostics: combating breast cancer stem cells;Cancer Stem Cells and Signaling Pathways;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3